A team of scientists has developed a miniature robotic device designed to enhance early detection and treatment of bowel cancer, the second-leading cause of cancer-related deaths worldwide. This cutting-edge innovation, which generates high-resolution 3D scans of the colon, represents a significant leap forward in medical robotics and cancer diagnostics.
The new robotic device is shaped like a mussel shell and navigates the digestive system with the aid of an external magnetic guide. This enables it to conduct scans that were previously unattainable, offering a revolutionary approach to diagnosing colorectal cancer at an early stage when it is most treatable.
“This minimally invasive robotic approach could significantly improve early diagnosis and, in future, allow targeted ultrasound-triggered medicine delivery,” said Nikita Greenidge of Leeds University, lead author of a study published in Science Robotics on Wednesday.
The device, developed by researchers from Leeds, Glasgow, and Edinburgh universities, is set to begin human trials next year following successful tests on pigs. Built using advanced 3D printing technology, the robot’s design is based on an oloid shape, which allows for greater mobility and effective contact with internal surfaces.
With a diameter comparable to a UK penny, the robot has been successfully tested on simulated models of the colon, esophagus, and stomach. By offering virtual cancer screening, it could eliminate delays, reduce costs, and bypass complications associated with traditional biopsy methods that require the extraction of bodily tissue. Researchers believe this innovation could streamline screening, diagnosis, and therapy into a single, efficient procedure, rather than the prolonged multi-stage processes that currently take weeks.
The new technology may be particularly beneficial for women, as their colons tend to be longer than men’s, making standard colonoscopies more difficult and often more painful. “Rapid, non-invasive solutions like this have the potential to revolutionize cancer diagnosis and treatment,” said Jane Nicholson, executive director of research at the UK’s Engineering and Physical Sciences Research Council, which co-funded the project.
Bowel cancer, also known as colorectal cancer, ranks as the third most common cancer worldwide, with 1.9 million new cases and 900,000 deaths reported in 2022, according to the World Health Organization’s Global Cancer Observatory. Alarmingly, colorectal cancer rates among individuals under 50 have been rising in several high-income countries, including the U.S., prompting investigations into potential dietary links, particularly the consumption of ultra-processed foods.
Professor Naeem Soomro, a council member and vice chair of the future of surgery at the Royal College of Surgeons of England, hailed the innovation as “potentially groundbreaking.” However, he emphasized the need for further studies to confirm its safety, clinical effectiveness, and cost efficiency before widespread adoption.
The development of this robotic device aligns with the increasing role of robotics in modern medicine, where they are already enhancing diagnostics and making surgical procedures less invasive. Robots have been deployed in blood vessel imaging, precision radiotherapy, and other medical applications, demonstrating their ability to improve patient outcomes.
The Financial Times reports that, if proven effective in human trials, this new robotic technology could mark a transformative moment in cancer detection and treatment, offering a faster, safer, and less invasive alternative to traditional screening methods.
